Home > News & Publications > News For 2007 > Magee Rehabilitation Hospital is One of First in Nation to Offer Breakthrough Technology Device for Patients with Stroke

Share | Print | Email Magee Rehabilitation Hospital is One of First in Nation to Offer Breakthrough Technology Device for Patients with Stroke

Magee Rehabilitation Hospital is One of First in Nation to Offer Breakthrough Technology Device for Patients with Stroke

Imagine technology so advanced that it may help stroke and other neurological patients regain lost mobility and achieve greater independence than they believed to be possible.This highly sophisticated technology is now a reality at Magee Rehabilitation Hospital. Through a partnership with Bioness Inc., Magee is among the first in the country to offer this breakthrough therapy and will serve as a regional evaluation and treatment site for patients interested in trying out the new device.

Central nervous system injuries often result in foot drop - leading to instability and difficulty walking. The NESS L300™ neuro-rehabilitation system is a revolution in Functional Electrical Stimulation (FES) technology, designed to help patients who experience foot drop to regain mobility and help "normalize" walking and gait. The L300 uses wireless communication to "talk" to its components, eliminating cumbersome wires, and allowing the therapist the ability to fine-tune settings while the patient is actually walking. This user-friendly system is appropriate for a broad range of conditions, including stroke, traumatic brain injury, multiple sclerosis, cerebral palsy, and incomplete spinal cord injury.

The L300 compliments and accelerates traditional therapy. The technology will be integrated into Magee's inpatient and outpatient rehab settings.

California-based Bioness Inc. was formed in 2004 by the Alfred Mann Foundation for Scientific Research, a world leader in medical technology, and NESS Ltd., a company headquartered in Israel that develops and manufactures neuroprosthetic and rehabilitation systems. Bioness Inc.'s mission is to deliver innovative devices and therapies to the field of physical medicine, taking rehabilitation to new levels of physical independence and productivity. Release of the L300 follows introduction of the NESS H200™, a Bioness technology designed to advance upper extremity rehabilitation that is also available at Magee.

Magee Rehabilitation Hospital, founded in 1958, is a 96-bed specialty medical rehabilitation hospital providing physical and cognitive rehabilitation services. Magee’s flagship facility is located in Center City Philadelphia. In addition to the main campus that offers comprehensive services for spinal cord injury, brain injury, stroke, orthopedic replacement, amputation, pain management and work injury, Magee provides an expanding out-patient network serving the surrounding communities. In 1985, Magee’s brain injury rehabilitation program became the first in the nation to be accredited by the Commission on the Accreditation of Rehabilitation Facilities. Magee partnered with Jefferson Hospital to create one of the nation’s 14 federally designated centers for spinal cord injury rehabilitation. Magee has been rated one of America’s leading rehabilitation hospitals by U.S. News&World Report. Magee provides treatment to more than 5,000 individuals annually. Magee is authorized to treat wounded military personnel returning from war. Magee is not an Obligated Group Affiliate.

Come Take a Tour

Professional Education Services

Designed to educate those in the rehabilitation community. Read more

Helpful Documents

Community Resource Guide
If you are you a member of the media interested in Magee, please contact:

Kim Shrack
Social Media and PR Manager
Magee Rehabilitation Hospital
1513 Race Street
Philadelphia, PA 19102
(215) 587-3363